Buckingham Research Downgrades to Omnicare (OCR) Neutral
More News related to OCR
- Omnicare Declares Quarterly Cash Dividend
- Omnicare Announces Resignation of Jeffrey W. Ubben from Board of Directors
- Omnicare to Host Analyst/Investor Day
- Omnicare to Present at the Credit Suisse Healthcare Conference
- Morgan Stanley Upgrades Omnicare (OCR) to Equalweight
More News related to Downgrades
- Merrill Smacks Down the REIT Space: Downgrades 29 Stocks, Upgrades 2
- Solars Rise as Merrill Downgrades First Solar (FSLR), SunPower (SPWRA)
- Merrill Lynch Downgrades Autodesk (ADSK) to Underperform
- Friedman Billings Downgrades Goodrich (GR) to Market Perform
- Friedman Billings Downgrades Spirit AeroSystems (SPR) to Market Perform
Buckingham Research downgrades Omnicare (Nasdaq: OCR) from Accumulate to Neutral.
Omnicare, Inc. (Omnicare) is a geriatric pharmaceutical services company. The Company operates in two segments: Pharmacy Services and Contract Research Organization Services (CRO Services).
Related Categories
DowngradesStocks Mentioned
+0.85Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
